how many people are taking glp 1 drugs The Multi-Sector Impacts of GLP-1RA The risk too many people

Nonetheless, in patients at high risk of sarcopenia, tailored management including nutritional optimization and concurrent resistance training should be considered to mitigate potential adverse consequences during pharmacologically induced weight loss [20]

Obesity is still widely viewed as a personal responsibility problem, despite scientific evidence to the contrary

Interestingly, higher incidence of diabetic retinopathy (DR) complications was noted in patients taking semaglutide (3.0%) compared to placebo (1.5%) in clinical trials, with greater risk in those with a history of DR [32]

Semaglutide users showed a 39% higher chance of delayed gastric emptying [23]

2016, p

According to this study, semaglutide use was associated with reductions in muscle mass and ASMI